Evidence mapPaperPMID 40327306Full record

ArticleMolecular neurobiology2025

Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis.

Yuangao Xu, Jieyu Xiong, Yikun Wu, Xiaoyu Wu, Hua Shi, Shuxiong Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuangao XuDepartment of Urology, Guizhou Provincial People's Hospital, Guiyang, China.ORCID http://orcid.org/0000-0001-5116-2278
Jieyu XiongDepartment for BioMedical Research, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0009-0007-1443-7042
Yikun WuDepartment of Urology, Guizhou Provincial People's Hospital, Guiyang, China.ORCID http://orcid.org/0000-0001-6904-1271
Xiaoyu WuFaculty of Medicine of Duisburg-Essen University, Essen, Germany.ORCID http://orcid.org/0009-0002-5426-5373
Hua ShiDepartment of Urology, Guizhou Provincial People's Hospital, Guiyang, China. 1024334058@qq.com.ORCID http://orcid.org/0000-0002-2319-1327
Shuxiong XuDepartment of Urology, Guizhou Provincial People's Hospital, Guiyang, China. xushuxiong123@sina.com.ORCID http://orcid.org/0000-0002-3601-2711

Funding

2021 National Natural Science Foundation Post Subsidy Individual Fund of China GPPH-NSFC-2021-10National Natural Science Foundation of China 82160145Science and Technology Fund of Guizhou Health Commission gzwkj2021-212
6 · The paper itself

Abstract

Despite lacking a genetic explanation for the causal link between multiple sclerosis (MS) and neuropathic bladder (NPB), our study aims to explore this causality and identify novel susceptibility genes for both phenotypes. We performed linkage disequilibrium score regression to assess SNP heritability for both phenotypes. Two-sample bidirectional Mendelian randomization (MR) analyses were conducted to evaluate causal relationships between MS and NPB. We performed pathway enrichment analysis on instrumental SNPs and applied summary-data-based MR (SMR) with protein and expression quantitative trait loci. Candidate susceptibility genes were further examined through colocalization analysis and differential expression studies. Our analyses indicate a substantial genetic contribution to both MS and NPB phenotypes. MR analysis revealed that MS progression increased NPB risk (OR = 1.126; 95% CI. 1.052-1.205; p < 0.001), with no evidence of reverse causality. Pathway analysis highlighted NIK/NF-kappaB signaling and autophagosome maturation as potentially shared mechanisms. SMR (p_FDR < 0.05) and colocalization analyses (PP.H4 > 0.75) identified NFKB1 and STAT3 as candidate susceptibility genes. Transcriptomic analyses confirmed significant differential expression of these genes (p < 0.05) between MS patients and healthy controls. Our findings established a causal relationship between MS progression and NPB risk, with NFKB1 and STAT3 emerging as promising therapeutic targets for MS-induced NPB.

Indexed as

Genetic Predisposition to DiseaseMendelian Randomization AnalysisMultiple SclerosisHumansLinkage DisequilibriumPolymorphism, Single NucleotideQuantitative Trait LociSTAT3 Transcription FactorSTAT3 Transcription FactorMendelian randomizationMultiple sclerosisNeuropathic bladderSusceptibility gene

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.